proxyvotesnow.com

Home › Companies › MARAVAI LIFESCIENCES HOLDINGS INC. › 2023-2024

MARAVAI LIFESCIENCES HOLDINGS INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and MARAVAI LIFESCIENCES HOLDINGS INC.’s Form 8-K, filed 2024-05-28 (Item 5.07 on EDGAR). Page generated 04 October 2026.

  • 6Ballot items
  • 229Asset managers
  • 1,510Fund votes
  • 2024-05-23Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore MARAVAI LIFESCIENCES HOLDINGS INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by MARAVAI LIFESCIENCES HOLDINGS INC.

These tallies are MARAVAI LIFESCIENCES HOLDINGS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-05-28 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

MARAVAI LIFESCIENCES HOLDINGS INC. — official shareholder meeting results, meeting held 2024-05-23
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Benjamin Daverman 193,739,240---- 33,663,9409,528,759 Majority: yes
Elect Director: Susannah Gray 193,773,793---- 33,629,3879,528,759 Majority: yes
Elect Director: Carl Hull 196,078,626---- 31,324,5549,528,759 Majority: yes
Elect Director: Constantine Mihas 191,415,297---- 35,987,8839,528,759 Majority: yes
Proposal 2: Proposal to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024. The appointment of Ernst & Young LLP as the Company's independent registered public accoun 236,288,478268,742374,720 ---- Passed
Proposal 3: Proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting. The Company's shareholders approved, on a non-binding and adviso 223,303,6544,747,004200,454 --8,680,827 Majority: yes

Source: MARAVAI LIFESCIENCES HOLDINGS INC., Form 8-K, filed with the SEC on 2024-05-28 — read the filing on EDGAR.

How asset managers voted at the MARAVAI LIFESCIENCES HOLDINGS INC. 2023-2024 meeting

Each item below shows how the 229 asset managers that disclosed a MARAVAI LIFESCIENCES HOLDINGS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. To approve, on a non-binding advisory basis, the compensation of Maravai's named executive officers, and

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 11 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 223,303,654AGAINST: 4,747,004

MARAVAI LIFESCIENCES HOLDINGS INC.’s own tally for this item (“Proposal 3: Proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting. The Company's shareholde”): 223,303,654 for, 4,747,004 against, per its Form 8-K filed 2024-05-28 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 226 asset managers below cast 96% of the shares they voted on this item FOR (78,370,857 for, 3,635,891 against).

FOR 95%
FOR: 78,370,857 (95.4%)AGAINST: 3,635,891 (4.4%)ABSTAIN: 176,200 (0.2%)
Largest asset managers voting on “To approve, on a non-binding advisory basis, the compensation of Maravai's named executive officers, and” at MARAVAI LIFESCIENCES HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard10,073,1770 00For
BlackRock5,687,4540 00For
BRAIDWELL LP5,567,9510 00For
MACKENZIE FINANCIAL CORP5,016,3160 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/4,054,0900 00For
Point723,604,9250 00For
MFS3,103,2990 00For
Fidelity3,073,0340 00For
Columbia Threadneedle2,532,8880 00For
Renaissance2,485,3220 00For
First Trust2,398,66968 00For
GLENMEDE FUND INC2,056,6540 00For
BAMCO INC /NY/1,974,3930 00For
State Street1,936,62736,517 00For
MARSHALL WACE, LLP01,858,692 00Against
GEODE CAPITAL MANAGEMENT, LLC1,823,4510 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)1,629,6760 00For
Charles Schwab1,283,8890 00For
Invesco1,152,9280 00For
Alyeska Investment Group, L.P.1,139,2820 00For
Granite Investment Partners, LLC1,021,5100 00For
Two Sigma956,0860 00For
Northern Trust938,3005,477 00For
AQR935,0950 00For
SYSTEMATIC FINANCIAL MANAGEMENT LP653,695127,920 00For

Showing the 25 largest of 226 asset managers. See all 226 in the interactive database.

2. To elect four nominees to the Board of Directors (3-year term expiring in 2027): Benjamin Daverman

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%WITHHELD 15%
FOR: 193,739,240WITHHELD: 33,663,940

MARAVAI LIFESCIENCES HOLDINGS INC.’s own tally for this item (“Elect Director: Benjamin Daverman”): 193,739,240 for, 33,663,940 withheld, per its Form 8-K filed 2024-05-28 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 65 asset managers below cast 100% of the shares they voted on this item FOR (22,545,130 for, 0 against).

FOR 69%ABSTAIN 31%
FOR: 22,545,130 (68.7%)ABSTAIN: 10,271,675 (31.3%)
Largest asset managers voting on “To elect four nominees to the Board of Directors (3-year term expiring in 2027): Benjamin Daverman” at MARAVAI LIFESCIENCES HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard9,880,9240 33,8000For
MFS00 3,103,2990Abstain
Columbia Threadneedle2,532,8880 00For
Fidelity2,271,6680 248,4560For
First Trust00 2,379,6170Abstain
BlackRock2,081,0750 00For
GLENMEDE FUND INC00 2,056,6540Abstain
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)1,629,6760 00For
Charles Schwab641,9290 00For
Dimensional00 582,1490Abstain
Legg Mason555,0370 00For
Invesco536,1380 00For
BUFFALO FUNDS512,4400 00For
WANGER ADVISORS TRUST480,0560 00For
Jackson National344,7170 27,4130For
Bridge Builder Trust19,3890 317,2120Abstain
TIAA00 236,2730Abstain
State Street240 212,6370Abstain
Transamerica193,8000 00For
Thrivent00 172,9330Abstain
Guardian Variable Products Trust142,4000 26,1830For
SEI120,0530 00For
JPMorgan108,0710 00For
AIG/SunAmerica00 103,1410Abstain
Russell Investments100,8070 00For

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

3. To elect four nominees to the Board of Directors (3-year term expiring in 2027): Susannah Gray

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%WITHHELD 15%
FOR: 193,773,793WITHHELD: 33,629,387

MARAVAI LIFESCIENCES HOLDINGS INC.’s own tally for this item (“Elect Director: Susannah Gray”): 193,773,793 for, 33,629,387 withheld, per its Form 8-K filed 2024-05-28 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 65 asset managers below cast 100% of the shares they voted on this item FOR (22,524,879 for, 0 against).

FOR 69%ABSTAIN 31%
FOR: 22,524,879 (68.6%)ABSTAIN: 10,291,926 (31.4%)
Largest asset managers voting on “To elect four nominees to the Board of Directors (3-year term expiring in 2027): Susannah Gray” at MARAVAI LIFESCIENCES HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard9,880,9240 33,8000For
MFS00 3,103,2990Abstain
Columbia Threadneedle2,532,8880 00For
Fidelity2,271,6680 248,4560For
First Trust00 2,379,6170Abstain
BlackRock2,081,0750 00For
GLENMEDE FUND INC00 2,056,6540Abstain
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)1,629,6760 00For
Charles Schwab641,9290 00For
Dimensional00 582,1490Abstain
Legg Mason555,0370 00For
Invesco536,1380 00For
BUFFALO FUNDS512,4400 00For
WANGER ADVISORS TRUST480,0560 00For
Jackson National344,7170 27,4130For
Bridge Builder Trust19,3890 317,2120Abstain
TIAA00 236,2730Abstain
State Street240 212,6370Abstain
Transamerica193,8000 00For
Thrivent00 172,9330Abstain
Guardian Variable Products Trust142,4000 26,1830For
SEI120,0530 00For
JPMorgan108,0710 00For
AIG/SunAmerica00 103,1410Abstain
Russell Investments100,8070 00For

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

4. To elect four nominees to the Board of Directors (3-year term expiring in 2027): Carl Hull

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

86% Majority: yes · of votes cast

FOR 86%14%
FOR: 196,078,626WITHHELD: 31,324,554

MARAVAI LIFESCIENCES HOLDINGS INC.’s own tally for this item (“Elect Director: Carl Hull”): 196,078,626 for, 31,324,554 withheld, per its Form 8-K filed 2024-05-28 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 65 asset managers below cast 100% of the shares they voted on this item FOR (26,385,517 for, 0 against).

FOR 80%ABSTAIN 20%
FOR: 26,385,517 (80.4%)ABSTAIN: 6,431,288 (19.6%)
Largest asset managers voting on “To elect four nominees to the Board of Directors (3-year term expiring in 2027): Carl Hull” at MARAVAI LIFESCIENCES HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard9,880,9240 33,8000For
MFS3,103,2990 00For
Columbia Threadneedle2,532,8880 00For
Fidelity2,271,6680 248,4560For
First Trust00 2,379,6170Abstain
BlackRock2,081,0750 00For
GLENMEDE FUND INC00 2,056,6540Abstain
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)1,629,6760 00For
Charles Schwab641,9290 00For
Dimensional00 582,1490Abstain
Legg Mason555,0370 00For
Invesco536,1380 00For
BUFFALO FUNDS512,4400 00For
WANGER ADVISORS TRUST480,0560 00For
Jackson National344,7170 27,4130For
Bridge Builder Trust336,6010 00For
TIAA236,2730 00For
State Street240 212,6370Abstain
Transamerica193,8000 00For
Thrivent00 172,9330Abstain
Guardian Variable Products Trust168,5830 00For
SEI120,0530 00For
JPMorgan108,0710 00For
AIG/SunAmerica00 103,1410Abstain
Russell Investments100,8070 00For

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

5. To elect four nominees to the Board of Directors (3-year term expiring in 2027): Constantine Mihas

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

84% Majority: yes · of votes cast

FOR 84%WITHHELD 16%
FOR: 191,415,297WITHHELD: 35,987,883

MARAVAI LIFESCIENCES HOLDINGS INC.’s own tally for this item (“Elect Director: Constantine Mihas”): 191,415,297 for, 35,987,883 withheld, per its Form 8-K filed 2024-05-28 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 65 asset managers below cast 100% of the shares they voted on this item FOR (20,487,423 for, 0 against).

FOR 62%ABSTAIN 38%
FOR: 20,487,423 (62.4%)ABSTAIN: 12,329,382 (37.6%)
Largest asset managers voting on “To elect four nominees to the Board of Directors (3-year term expiring in 2027): Constantine Mihas” at MARAVAI LIFESCIENCES HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard9,880,9240 33,8000For
MFS00 3,103,2990Abstain
Columbia Threadneedle2,532,8880 00For
Fidelity2,271,6680 248,4560For
First Trust00 2,379,6170Abstain
BlackRock2,081,0750 00For
GLENMEDE FUND INC00 2,056,6540Abstain
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)00 1,629,6760Abstain
Charles Schwab641,9290 00For
Dimensional00 582,1490Abstain
Legg Mason555,0370 00For
Invesco536,1380 00For
BUFFALO FUNDS512,4400 00For
WANGER ADVISORS TRUST480,0560 00For
Jackson National00 372,1300Abstain
Bridge Builder Trust19,3890 317,2120Abstain
TIAA00 236,2730Abstain
State Street240 212,6370Abstain
Transamerica193,8000 00For
Thrivent00 172,9330Abstain
Guardian Variable Products Trust142,4000 26,1830For
SEI120,0530 00For
JPMorgan108,0710 00For
AIG/SunAmerica00 103,1410Abstain
Russell Investments100,8070 00For

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

6. To ratify the appointment of Ernst & Young LLP as Maravai's independent registered public accounting firm for the year ending December 31, 2024;

AUDIT-RELATEDCompany result: Passed

Combines 4 wordings of this item as funds reported it.

99.8% Passed · of votes cast

FOR 99.8%
FOR: 236,288,478AGAINST: 268,742

MARAVAI LIFESCIENCES HOLDINGS INC.’s own tally for this item (“Proposal 2: Proposal to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024. The appointment of Ernst & Young LLP as the Compan”): 236,288,478 for, 268,742 against — passed, per its Form 8-K filed 2024-05-28 (Item 5.07). Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 65 asset managers below cast 99.9% of the shares they voted on this item FOR (32,814,843 for, 2 against).

FOR 99.9%
FOR: 32,814,843 (100.0%)AGAINST: 2 (0.0%)ABSTAIN: 1,960 (0.0%)
Largest asset managers voting on “To ratify the appointment of Ernst & Young LLP as Maravai's independent registered public accounting firm for ” at MARAVAI LIFESCIENCES HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard9,914,7240 00For
MFS3,103,2990 00For
Columbia Threadneedle2,532,8880 00For
Fidelity2,520,1240 00For
First Trust2,379,6170 00For
BlackRock2,081,0750 00For
GLENMEDE FUND INC2,056,6540 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)1,629,6760 00For
Charles Schwab641,9290 00For
Dimensional582,1490 00For
Legg Mason555,0370 00For
Invesco536,1380 00For
BUFFALO FUNDS512,4400 00For
WANGER ADVISORS TRUST480,0560 00For
Jackson National372,1300 00For
Bridge Builder Trust336,6010 00For
TIAA236,2730 00For
State Street212,6592 00For
Transamerica193,8000 00For
Thrivent172,9330 00For
Guardian Variable Products Trust168,5830 00For
SEI120,0530 00For
JPMorgan108,0710 00For
AIG/SunAmerica103,1410 00For
Russell Investments100,8070 00For

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

Largest MARAVAI LIFESCIENCES HOLDINGS INC. shareholders voting in 2023-2024

Ranked by the number of MARAVAI LIFESCIENCES HOLDINGS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 132,333,000 shares outstanding at the time of that meeting.

Top MARAVAI LIFESCIENCES HOLDINGS INC. shareholders by shares voted, 2023-2024
#Asset manager % of shares outstanding
1Vanguard 7.61%
2BlackRock 4.30%
3BRAIDWELL LP 4.21%
4MACKENZIE FINANCIAL CORP 3.79%
5MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 3.06%
6Point72 2.72%
7MFS 2.35%
8Fidelity 2.32%
9Columbia Threadneedle 1.91%
10Renaissance 1.88%

Reported MARAVAI LIFESCIENCES HOLDINGS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

MARAVAI LIFESCIENCES HOLDINGS INC. beneficial owners on record for the 2023-2024 proxy season
Holder % outstanding Disclosure
GTCR 16.38% DEF14A
Maravai Life Sciences Holdings, LLC 15.23% 13G
West Capital Management LP 8.77% DEF14A
BlackRock 6.88% 13F
Vanguard Group 5.38% 13F
Renaissance Technologies 2.43% 13F
Morgan Stanley 2.18% 13F
State Street 1.54% 13F
Geode Capital 1.38% 13F
D.E. Shaw 1.21% 13F

Percentages above are of 132,333,000 shares outstanding, as reported by MARAVAI LIFESCIENCES HOLDINGS INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from MARAVAI LIFESCIENCES HOLDINGS INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At MARAVAI LIFESCIENCES HOLDINGS INC.'s shareholder meeting held 2024-05-23, in the 2023-2024 proxy season, 229 asset managers reported how they voted on 6 ballot items in their SEC Form N-PX filings, covering 1,510 separate fund positions. On the most widely held item on that ballot — To approve, on a non-binding advisory basis, the compensation of Maravai's named executive… — FOR was 98% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: MARAVAI LIFESCIENCES HOLDINGS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-05-28.

MARAVAI LIFESCIENCES HOLDINGS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.